Novel Allosteric Modulation of the Human 5-HT3A Receptor by the Clinically Used Drugs Piperazine and Hydroxyzine
- DOI
- 10.1016/j.neuropharm.2026.111196
- Published
- 2026-09
- Container
- Neuropharmacology
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.neuropharm.2026.111196,
title = {Novel Allosteric Modulation of the Human 5-HT3A Receptor by the Clinically Used Drugs Piperazine and Hydroxyzine},
author = {Noelia Rodriguez Araujo and Jeremías Corradi and Ignacio Bergé and Cecilia Bouzat},
year = {2026},
journal = {Neuropharmacology},
doi = {10.1016/j.neuropharm.2026.111196},
url = {https://doi.org/10.1016/j.neuropharm.2026.111196}
}RIS
TY - JOUR TI - Novel Allosteric Modulation of the Human 5-HT3A Receptor by the Clinically Used Drugs Piperazine and Hydroxyzine AU - Noelia Rodriguez Araujo AU - Jeremías Corradi AU - Ignacio Bergé AU - Cecilia Bouzat PY - 2026 JO - Neuropharmacology DO - 10.1016/j.neuropharm.2026.111196 UR - https://doi.org/10.1016/j.neuropharm.2026.111196 ER -
APA
Araujo, N. R., Corradi, J., Bergé, I., & Bouzat, C. (2026). Novel Allosteric Modulation of the Human 5-HT3A Receptor by the Clinically Used Drugs Piperazine and Hydroxyzine. Neuropharmacology. https://doi.org/10.1016/j.neuropharm.2026.111196
Source records
- crossref · retrieved 2026-09-26T11:43:09.769Z